Category: Articles

Key takeaways

• Female genital mutilation is abuse, is illegal in the UK and should be handled as both a health and safeguarding concern.
• FGM can cause immediate and long-term physical, sexual, pregnancy and mental health effects, even years after it happened.
• Support should be trauma-informed, confidential where possible, and clear about safeguarding duties for girls and women at risk.
• Deinfibulation may help some people with type 3 FGM, painful sex, urinary problems, pregnancy or birth planning after specialist assessment.
• Call 999 if someone is in immediate danger; use NHS 111 or specialist services for urgent health concerns.

Overview

FGM can be linked with trauma, anxiety, depression, flashbacks and sexual distress, so psychological support may be needed.

Female genital mutilation means deliberately cutting, injuring or changing female genital tissue for non-medical reasons. It is sometimes called cutting or female circumcision, but clinical writing should be clear that it is harmful and illegal in the UK. People affected by FGM may be children, teenagers or adults, and they may need safeguarding, medical care, maternity planning, sexual health support and psychological help.

The original article and thin draft were read locally before this rewrite. This replacement keeps the article’s specific focus while meeting current editorial standards: trauma-informed language, clear safeguarding, practical clinical detail and relevant UK authority sources. The article is educational only and cannot replace urgent protection or specialist assessment.

Types and health effects

FGM is often classified into types based on what tissue was cut or sealed. Type 1 involves partial or total removal of the clitoral glans or prepuce. Type 2 involves removal of the clitoral glans and labia minora, with or without labia majora. Type 3, infibulation, narrows the vaginal opening by creating a seal. Type 4 includes other harmful procedures such as pricking, piercing, scraping or cauterising for non-medical reasons.

Immediate effects can include severe pain, bleeding, shock, infection, urinary retention and injury to nearby tissues. Long-term effects can include chronic pain, painful periods, difficulty passing urine, recurrent infections, cysts, scarring, painful sex, reduced sexual wellbeing, childbirth complications and psychological trauma. The severity of visible cutting does not always predict the severity of distress or symptoms.

Safeguarding and the law

FGM is illegal in the UK. It is also illegal to take a girl abroad to have FGM carried out. Professionals may have safeguarding and mandatory reporting duties when a child is at risk or FGM is identified in someone under 18. Adults affected by FGM should be offered respectful care, information and choices, but safeguarding still matters if a child or another person may be at risk.

Risk factors can include a family history of FGM, planned travel to a country or community where FGM is practised, relatives discussing a special ceremony, pressure from family members, or a girl being withdrawn from school or healthcare before travel. Risk assessment should be careful and non-stigmatising: the goal is protection, not blaming a whole community.

Clinical care and deinfibulation

Care may involve a GP, specialist FGM clinic, gynaecologist, midwife, sexual health service, safeguarding team or mental health professional. Assessment should be consent-based and should explain what examination involves before it happens. Some people may not know what type of FGM they have, may have never been examined, or may fear judgement. Sensitive explanation and choice are essential.

Deinfibulation is a procedure to open scar tissue in type 3 FGM. It may be discussed for urinary or menstrual problems, painful sex, smear testing, pregnancy care or birth planning. Suitability is confirmed after specialist assessment. People should be told what the procedure involves, pain relief options, healing time, sexual activity advice, psychological support and whether follow-up is needed.

Sex, pregnancy and mental health

FGM can affect sex through pain, fear, reduced sensation, difficulty with penetration, flashbacks or relationship strain. Sexual difficulties after FGM are health concerns, not personal failings. Support may include medical assessment, deinfibulation where relevant, pelvic health physiotherapy, psychosexual therapy, trauma support and careful use of lubricants or vaginal moisturisers if dryness or pain is present.

Pregnancy care should ask about FGM early so maternity teams can plan safely. Type 3 FGM may need deinfibulation before pregnancy, during pregnancy or in labour depending on circumstances and local specialist advice. Mental health effects can include anxiety, depression, post-traumatic stress symptoms, shame, anger or numbness. Survivors should be offered support that respects privacy, culture, language needs and personal safety.

Getting help and urgent protection

If a girl or woman is in immediate danger of FGM, call 999. If there is a concern that a child may be taken abroad for FGM, contact police, children’s social care or a safeguarding professional urgently. Adults can ask a GP, midwife, sexual health clinic or specialist FGM service for help with symptoms, deinfibulation, pregnancy planning, counselling or safeguarding worries.

Healthcare should never require a survivor to retell traumatic details repeatedly when notes can be shared safely with consent. Interpreting should be arranged professionally where needed, rather than relying on family members. If privacy is unsafe at home, services should discuss safe contact methods before sending letters, texts or appointment details.

When to seek medical advice

Seek medical advice for pelvic pain, painful sex, urinary problems, recurrent infections, period problems, pregnancy, flashbacks, anxiety, depression or concerns about a girl at risk. Prompt help is important for bleeding, fever, severe pain, inability to pass urine or immediate safeguarding danger.

Use NHS 111 for urgent health advice when symptoms are worrying but not immediately life-threatening. Call 999 if someone is in immediate danger, has severe bleeding, collapses or needs emergency protection.

Reader review points

Care for FGM should move at the survivor’s pace unless there is immediate danger. The person may need to know who will be in the room, whether an examination is necessary, whether they can stop at any time, how information will be recorded, and what will happen if a child may be at risk. Clear explanation can reduce the chance that healthcare itself feels frightening or disempowering.

Professionals should avoid assumptions about culture, sexuality, family relationships or what the person wants next. Some survivors want urgent treatment, some want time to understand their anatomy, some need maternity planning, and some mainly need psychological support or safeguarding advice. The most useful plan is specific, trauma-informed and documented, with safe contact arrangements if privacy at home is uncertain.

Where children may be at risk, delay can increase harm. Safeguarding action should be proportionate, documented and focused on protection. For adults, care should still be empowering: explain choices, ask permission, use professional interpreters where needed, and check whether letters, calls or digital messages could place the person at risk.

Sources

• NHS, Female genital mutilation: https://www.nhs.uk/conditions/female-genital-mutilation-fgm/
  Relevance: Explains FGM, health effects, safeguarding, support and treatment options in UK patient language.
• GOV.UK, Female genital mutilation guidance: https://www.gov.uk/government/publications/female-genital-mutilation-guidelines
  Relevance: Provides statutory and multi-agency safeguarding guidance relevant to risk, reporting and protection.
• RCOG, Female genital mutilation and its management: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/female-genital-mutilation-and-its-management-green-top-guideline-no-53/
  Relevance: Gives professional guidance on clinical care, pregnancy, deinfibulation and safeguarding.
• NHS, Help after rape and sexual assault: https://www.nhs.uk/live-well/sexual-health/help-after-rape-and-sexual-assault/
  Relevance: Supports trauma-informed signposting for people needing urgent sexual violence or safeguarding support.
• WHO, Female genital mutilation: https://www.who.int/news-room/fact-sheets/detail/female-genital-mutilation
  Relevance: Provides global clinical and public health context on FGM types, harms and prevention.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Female genital mutilation is abuse, is illegal in the UK and should be handled as both a health and safeguarding concern.
• FGM can cause immediate and long-term physical, sexual, pregnancy and mental health effects, even years after it happened.
• Support should be trauma-informed, confidential where possible, and clear about safeguarding duties for girls and women at risk.
• Deinfibulation may help some people with type 3 FGM, painful sex, urinary problems, pregnancy or birth planning after specialist assessment.
• Call 999 if someone is in immediate danger; use NHS 111 or specialist services for urgent health concerns.

Overview

Deinfibulation is a procedure to open scar tissue in type 3 FGM and may be discussed before sex, pregnancy or birth.

Female genital mutilation means deliberately cutting, injuring or changing female genital tissue for non-medical reasons. It is sometimes called cutting or female circumcision, but clinical writing should be clear that it is harmful and illegal in the UK. People affected by FGM may be children, teenagers or adults, and they may need safeguarding, medical care, maternity planning, sexual health support and psychological help.

The original article and thin draft were read locally before this rewrite. This replacement keeps the article’s specific focus while meeting current editorial standards: trauma-informed language, clear safeguarding, practical clinical detail and relevant UK authority sources. The article is educational only and cannot replace urgent protection or specialist assessment.

Types and health effects

FGM is often classified into types based on what tissue was cut or sealed. Type 1 involves partial or total removal of the clitoral glans or prepuce. Type 2 involves removal of the clitoral glans and labia minora, with or without labia majora. Type 3, infibulation, narrows the vaginal opening by creating a seal. Type 4 includes other harmful procedures such as pricking, piercing, scraping or cauterising for non-medical reasons.

Immediate effects can include severe pain, bleeding, shock, infection, urinary retention and injury to nearby tissues. Long-term effects can include chronic pain, painful periods, difficulty passing urine, recurrent infections, cysts, scarring, painful sex, reduced sexual wellbeing, childbirth complications and psychological trauma. The severity of visible cutting does not always predict the severity of distress or symptoms.

Safeguarding and the law

FGM is illegal in the UK. It is also illegal to take a girl abroad to have FGM carried out. Professionals may have safeguarding and mandatory reporting duties when a child is at risk or FGM is identified in someone under 18. Adults affected by FGM should be offered respectful care, information and choices, but safeguarding still matters if a child or another person may be at risk.

Risk factors can include a family history of FGM, planned travel to a country or community where FGM is practised, relatives discussing a special ceremony, pressure from family members, or a girl being withdrawn from school or healthcare before travel. Risk assessment should be careful and non-stigmatising: the goal is protection, not blaming a whole community.

Clinical care and deinfibulation

Care may involve a GP, specialist FGM clinic, gynaecologist, midwife, sexual health service, safeguarding team or mental health professional. Assessment should be consent-based and should explain what examination involves before it happens. Some people may not know what type of FGM they have, may have never been examined, or may fear judgement. Sensitive explanation and choice are essential.

Deinfibulation is a procedure to open scar tissue in type 3 FGM. It may be discussed for urinary or menstrual problems, painful sex, smear testing, pregnancy care or birth planning. Suitability is confirmed after specialist assessment. People should be told what the procedure involves, pain relief options, healing time, sexual activity advice, psychological support and whether follow-up is needed.

Sex, pregnancy and mental health

FGM can affect sex through pain, fear, reduced sensation, difficulty with penetration, flashbacks or relationship strain. Sexual difficulties after FGM are health concerns, not personal failings. Support may include medical assessment, deinfibulation where relevant, pelvic health physiotherapy, psychosexual therapy, trauma support and careful use of lubricants or vaginal moisturisers if dryness or pain is present.

Pregnancy care should ask about FGM early so maternity teams can plan safely. Type 3 FGM may need deinfibulation before pregnancy, during pregnancy or in labour depending on circumstances and local specialist advice. Mental health effects can include anxiety, depression, post-traumatic stress symptoms, shame, anger or numbness. Survivors should be offered support that respects privacy, culture, language needs and personal safety.

Getting help and urgent protection

If a girl or woman is in immediate danger of FGM, call 999. If there is a concern that a child may be taken abroad for FGM, contact police, children’s social care or a safeguarding professional urgently. Adults can ask a GP, midwife, sexual health clinic or specialist FGM service for help with symptoms, deinfibulation, pregnancy planning, counselling or safeguarding worries.

Healthcare should never require a survivor to retell traumatic details repeatedly when notes can be shared safely with consent. Interpreting should be arranged professionally where needed, rather than relying on family members. If privacy is unsafe at home, services should discuss safe contact methods before sending letters, texts or appointment details.

When to seek medical advice

Seek medical advice for pelvic pain, painful sex, urinary problems, recurrent infections, period problems, pregnancy, flashbacks, anxiety, depression or concerns about a girl at risk. Prompt help is important for bleeding, fever, severe pain, inability to pass urine or immediate safeguarding danger.

Use NHS 111 for urgent health advice when symptoms are worrying but not immediately life-threatening. Call 999 if someone is in immediate danger, has severe bleeding, collapses or needs emergency protection.

Reader review points

Care for FGM should move at the survivor’s pace unless there is immediate danger. The person may need to know who will be in the room, whether an examination is necessary, whether they can stop at any time, how information will be recorded, and what will happen if a child may be at risk. Clear explanation can reduce the chance that healthcare itself feels frightening or disempowering.

Professionals should avoid assumptions about culture, sexuality, family relationships or what the person wants next. Some survivors want urgent treatment, some want time to understand their anatomy, some need maternity planning, and some mainly need psychological support or safeguarding advice. The most useful plan is specific, trauma-informed and documented, with safe contact arrangements if privacy at home is uncertain.

Where children may be at risk, delay can increase harm. Safeguarding action should be proportionate, documented and focused on protection. For adults, care should still be empowering: explain choices, ask permission, use professional interpreters where needed, and check whether letters, calls or digital messages could place the person at risk.

Sources

• NHS, Female genital mutilation: https://www.nhs.uk/conditions/female-genital-mutilation-fgm/
  Relevance: Explains FGM, health effects, safeguarding, support and treatment options in UK patient language.
• GOV.UK, Female genital mutilation guidance: https://www.gov.uk/government/publications/female-genital-mutilation-guidelines
  Relevance: Provides statutory and multi-agency safeguarding guidance relevant to risk, reporting and protection.
• RCOG, Female genital mutilation and its management: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/female-genital-mutilation-and-its-management-green-top-guideline-no-53/
  Relevance: Gives professional guidance on clinical care, pregnancy, deinfibulation and safeguarding.
• NHS, Help after rape and sexual assault: https://www.nhs.uk/live-well/sexual-health/help-after-rape-and-sexual-assault/
  Relevance: Supports trauma-informed signposting for people needing urgent sexual violence or safeguarding support.
• WHO, Female genital mutilation: https://www.who.int/news-room/fact-sheets/detail/female-genital-mutilation
  Relevance: Provides global clinical and public health context on FGM types, harms and prevention.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Female genital mutilation is abuse, is illegal in the UK and should be handled as both a health and safeguarding concern.
• FGM can cause immediate and long-term physical, sexual, pregnancy and mental health effects, even years after it happened.
• Support should be trauma-informed, confidential where possible, and clear about safeguarding duties for girls and women at risk.
• Deinfibulation may help some people with type 3 FGM, painful sex, urinary problems, pregnancy or birth planning after specialist assessment.
• Call 999 if someone is in immediate danger; use NHS 111 or specialist services for urgent health concerns.

Overview

Explaining why FGM is carried out must never normalise it; the practice is abuse and is illegal in the UK.

Female genital mutilation means deliberately cutting, injuring or changing female genital tissue for non-medical reasons. It is sometimes called cutting or female circumcision, but clinical writing should be clear that it is harmful and illegal in the UK. People affected by FGM may be children, teenagers or adults, and they may need safeguarding, medical care, maternity planning, sexual health support and psychological help.

The original article and thin draft were read locally before this rewrite. This replacement keeps the article’s specific focus while meeting current editorial standards: trauma-informed language, clear safeguarding, practical clinical detail and relevant UK authority sources. The article is educational only and cannot replace urgent protection or specialist assessment.

Types and health effects

FGM is often classified into types based on what tissue was cut or sealed. Type 1 involves partial or total removal of the clitoral glans or prepuce. Type 2 involves removal of the clitoral glans and labia minora, with or without labia majora. Type 3, infibulation, narrows the vaginal opening by creating a seal. Type 4 includes other harmful procedures such as pricking, piercing, scraping or cauterising for non-medical reasons.

Immediate effects can include severe pain, bleeding, shock, infection, urinary retention and injury to nearby tissues. Long-term effects can include chronic pain, painful periods, difficulty passing urine, recurrent infections, cysts, scarring, painful sex, reduced sexual wellbeing, childbirth complications and psychological trauma. The severity of visible cutting does not always predict the severity of distress or symptoms.

Safeguarding and the law

FGM is illegal in the UK. It is also illegal to take a girl abroad to have FGM carried out. Professionals may have safeguarding and mandatory reporting duties when a child is at risk or FGM is identified in someone under 18. Adults affected by FGM should be offered respectful care, information and choices, but safeguarding still matters if a child or another person may be at risk.

Risk factors can include a family history of FGM, planned travel to a country or community where FGM is practised, relatives discussing a special ceremony, pressure from family members, or a girl being withdrawn from school or healthcare before travel. Risk assessment should be careful and non-stigmatising: the goal is protection, not blaming a whole community.

Clinical care and deinfibulation

Care may involve a GP, specialist FGM clinic, gynaecologist, midwife, sexual health service, safeguarding team or mental health professional. Assessment should be consent-based and should explain what examination involves before it happens. Some people may not know what type of FGM they have, may have never been examined, or may fear judgement. Sensitive explanation and choice are essential.

Deinfibulation is a procedure to open scar tissue in type 3 FGM. It may be discussed for urinary or menstrual problems, painful sex, smear testing, pregnancy care or birth planning. Suitability is confirmed after specialist assessment. People should be told what the procedure involves, pain relief options, healing time, sexual activity advice, psychological support and whether follow-up is needed.

Sex, pregnancy and mental health

FGM can affect sex through pain, fear, reduced sensation, difficulty with penetration, flashbacks or relationship strain. Sexual difficulties after FGM are health concerns, not personal failings. Support may include medical assessment, deinfibulation where relevant, pelvic health physiotherapy, psychosexual therapy, trauma support and careful use of lubricants or vaginal moisturisers if dryness or pain is present.

Pregnancy care should ask about FGM early so maternity teams can plan safely. Type 3 FGM may need deinfibulation before pregnancy, during pregnancy or in labour depending on circumstances and local specialist advice. Mental health effects can include anxiety, depression, post-traumatic stress symptoms, shame, anger or numbness. Survivors should be offered support that respects privacy, culture, language needs and personal safety.

Getting help and urgent protection

If a girl or woman is in immediate danger of FGM, call 999. If there is a concern that a child may be taken abroad for FGM, contact police, children’s social care or a safeguarding professional urgently. Adults can ask a GP, midwife, sexual health clinic or specialist FGM service for help with symptoms, deinfibulation, pregnancy planning, counselling or safeguarding worries.

Healthcare should never require a survivor to retell traumatic details repeatedly when notes can be shared safely with consent. Interpreting should be arranged professionally where needed, rather than relying on family members. If privacy is unsafe at home, services should discuss safe contact methods before sending letters, texts or appointment details.

When to seek medical advice

Seek medical advice for pelvic pain, painful sex, urinary problems, recurrent infections, period problems, pregnancy, flashbacks, anxiety, depression or concerns about a girl at risk. Prompt help is important for bleeding, fever, severe pain, inability to pass urine or immediate safeguarding danger.

Use NHS 111 for urgent health advice when symptoms are worrying but not immediately life-threatening. Call 999 if someone is in immediate danger, has severe bleeding, collapses or needs emergency protection.

Reader review points

Care for FGM should move at the survivor’s pace unless there is immediate danger. The person may need to know who will be in the room, whether an examination is necessary, whether they can stop at any time, how information will be recorded, and what will happen if a child may be at risk. Clear explanation can reduce the chance that healthcare itself feels frightening or disempowering.

Professionals should avoid assumptions about culture, sexuality, family relationships or what the person wants next. Some survivors want urgent treatment, some want time to understand their anatomy, some need maternity planning, and some mainly need psychological support or safeguarding advice. The most useful plan is specific, trauma-informed and documented, with safe contact arrangements if privacy at home is uncertain.

Where children may be at risk, delay can increase harm. Safeguarding action should be proportionate, documented and focused on protection. For adults, care should still be empowering: explain choices, ask permission, use professional interpreters where needed, and check whether letters, calls or digital messages could place the person at risk.

Sources

• NHS, Female genital mutilation: https://www.nhs.uk/conditions/female-genital-mutilation-fgm/
  Relevance: Explains FGM, health effects, safeguarding, support and treatment options in UK patient language.
• GOV.UK, Female genital mutilation guidance: https://www.gov.uk/government/publications/female-genital-mutilation-guidelines
  Relevance: Provides statutory and multi-agency safeguarding guidance relevant to risk, reporting and protection.
• RCOG, Female genital mutilation and its management: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/female-genital-mutilation-and-its-management-green-top-guideline-no-53/
  Relevance: Gives professional guidance on clinical care, pregnancy, deinfibulation and safeguarding.
• NHS, Help after rape and sexual assault: https://www.nhs.uk/live-well/sexual-health/help-after-rape-and-sexual-assault/
  Relevance: Supports trauma-informed signposting for people needing urgent sexual violence or safeguarding support.
• WHO, Female genital mutilation: https://www.who.int/news-room/fact-sheets/detail/female-genital-mutilation
  Relevance: Provides global clinical and public health context on FGM types, harms and prevention.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Female genital mutilation is abuse, is illegal in the UK and should be handled as both a health and safeguarding concern.
• FGM can cause immediate and long-term physical, sexual, pregnancy and mental health effects, even years after it happened.
• Support should be trauma-informed, confidential where possible, and clear about safeguarding duties for girls and women at risk.
• Deinfibulation may help some people with type 3 FGM, painful sex, urinary problems, pregnancy or birth planning after specialist assessment.
• Call 999 if someone is in immediate danger; use NHS 111 or specialist services for urgent health concerns.

Overview

UK law prohibits FGM and includes safeguarding duties designed to protect girls and women at risk.

Female genital mutilation means deliberately cutting, injuring or changing female genital tissue for non-medical reasons. It is sometimes called cutting or female circumcision, but clinical writing should be clear that it is harmful and illegal in the UK. People affected by FGM may be children, teenagers or adults, and they may need safeguarding, medical care, maternity planning, sexual health support and psychological help.

The original article and thin draft were read locally before this rewrite. This replacement keeps the article’s specific focus while meeting current editorial standards: trauma-informed language, clear safeguarding, practical clinical detail and relevant UK authority sources. The article is educational only and cannot replace urgent protection or specialist assessment.

Types and health effects

FGM is often classified into types based on what tissue was cut or sealed. Type 1 involves partial or total removal of the clitoral glans or prepuce. Type 2 involves removal of the clitoral glans and labia minora, with or without labia majora. Type 3, infibulation, narrows the vaginal opening by creating a seal. Type 4 includes other harmful procedures such as pricking, piercing, scraping or cauterising for non-medical reasons.

Immediate effects can include severe pain, bleeding, shock, infection, urinary retention and injury to nearby tissues. Long-term effects can include chronic pain, painful periods, difficulty passing urine, recurrent infections, cysts, scarring, painful sex, reduced sexual wellbeing, childbirth complications and psychological trauma. The severity of visible cutting does not always predict the severity of distress or symptoms.

Safeguarding and the law

FGM is illegal in the UK. It is also illegal to take a girl abroad to have FGM carried out. Professionals may have safeguarding and mandatory reporting duties when a child is at risk or FGM is identified in someone under 18. Adults affected by FGM should be offered respectful care, information and choices, but safeguarding still matters if a child or another person may be at risk.

Risk factors can include a family history of FGM, planned travel to a country or community where FGM is practised, relatives discussing a special ceremony, pressure from family members, or a girl being withdrawn from school or healthcare before travel. Risk assessment should be careful and non-stigmatising: the goal is protection, not blaming a whole community.

Clinical care and deinfibulation

Care may involve a GP, specialist FGM clinic, gynaecologist, midwife, sexual health service, safeguarding team or mental health professional. Assessment should be consent-based and should explain what examination involves before it happens. Some people may not know what type of FGM they have, may have never been examined, or may fear judgement. Sensitive explanation and choice are essential.

Deinfibulation is a procedure to open scar tissue in type 3 FGM. It may be discussed for urinary or menstrual problems, painful sex, smear testing, pregnancy care or birth planning. Suitability is confirmed after specialist assessment. People should be told what the procedure involves, pain relief options, healing time, sexual activity advice, psychological support and whether follow-up is needed.

Sex, pregnancy and mental health

FGM can affect sex through pain, fear, reduced sensation, difficulty with penetration, flashbacks or relationship strain. Sexual difficulties after FGM are health concerns, not personal failings. Support may include medical assessment, deinfibulation where relevant, pelvic health physiotherapy, psychosexual therapy, trauma support and careful use of lubricants or vaginal moisturisers if dryness or pain is present.

Pregnancy care should ask about FGM early so maternity teams can plan safely. Type 3 FGM may need deinfibulation before pregnancy, during pregnancy or in labour depending on circumstances and local specialist advice. Mental health effects can include anxiety, depression, post-traumatic stress symptoms, shame, anger or numbness. Survivors should be offered support that respects privacy, culture, language needs and personal safety.

Getting help and urgent protection

If a girl or woman is in immediate danger of FGM, call 999. If there is a concern that a child may be taken abroad for FGM, contact police, children’s social care or a safeguarding professional urgently. Adults can ask a GP, midwife, sexual health clinic or specialist FGM service for help with symptoms, deinfibulation, pregnancy planning, counselling or safeguarding worries.

Healthcare should never require a survivor to retell traumatic details repeatedly when notes can be shared safely with consent. Interpreting should be arranged professionally where needed, rather than relying on family members. If privacy is unsafe at home, services should discuss safe contact methods before sending letters, texts or appointment details.

When to seek medical advice

Seek medical advice for pelvic pain, painful sex, urinary problems, recurrent infections, period problems, pregnancy, flashbacks, anxiety, depression or concerns about a girl at risk. Prompt help is important for bleeding, fever, severe pain, inability to pass urine or immediate safeguarding danger.

Use NHS 111 for urgent health advice when symptoms are worrying but not immediately life-threatening. Call 999 if someone is in immediate danger, has severe bleeding, collapses or needs emergency protection.

Reader review points

Care for FGM should move at the survivor’s pace unless there is immediate danger. The person may need to know who will be in the room, whether an examination is necessary, whether they can stop at any time, how information will be recorded, and what will happen if a child may be at risk. Clear explanation can reduce the chance that healthcare itself feels frightening or disempowering.

Professionals should avoid assumptions about culture, sexuality, family relationships or what the person wants next. Some survivors want urgent treatment, some want time to understand their anatomy, some need maternity planning, and some mainly need psychological support or safeguarding advice. The most useful plan is specific, trauma-informed and documented, with safe contact arrangements if privacy at home is uncertain.

Where children may be at risk, delay can increase harm. Safeguarding action should be proportionate, documented and focused on protection. For adults, care should still be empowering: explain choices, ask permission, use professional interpreters where needed, and check whether letters, calls or digital messages could place the person at risk.

Sources

• NHS, Female genital mutilation: https://www.nhs.uk/conditions/female-genital-mutilation-fgm/
  Relevance: Explains FGM, health effects, safeguarding, support and treatment options in UK patient language.
• GOV.UK, Female genital mutilation guidance: https://www.gov.uk/government/publications/female-genital-mutilation-guidelines
  Relevance: Provides statutory and multi-agency safeguarding guidance relevant to risk, reporting and protection.
• RCOG, Female genital mutilation and its management: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/female-genital-mutilation-and-its-management-green-top-guideline-no-53/
  Relevance: Gives professional guidance on clinical care, pregnancy, deinfibulation and safeguarding.
• NHS, Help after rape and sexual assault: https://www.nhs.uk/live-well/sexual-health/help-after-rape-and-sexual-assault/
  Relevance: Supports trauma-informed signposting for people needing urgent sexual violence or safeguarding support.
• WHO, Female genital mutilation: https://www.who.int/news-room/fact-sheets/detail/female-genital-mutilation
  Relevance: Provides global clinical and public health context on FGM types, harms and prevention.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Menopause and perimenopause can affect periods, sleep, mood, skin, joints, bladder, vaginal tissue, sex and long-term health.
• Early menopause and premature ovarian insufficiency need careful assessment because bone, heart, fertility and emotional health may be affected.
• Diagnosis is often clinical after age 45, while younger women or complex cases may need blood tests, pregnancy checks or specialist review.
• Treatment may include information, lifestyle support, HRT where suitable, vaginal treatments, non-hormonal options and regular review.
• Seek medical advice for bleeding after menopause, very heavy bleeding, severe mood symptoms, pelvic pain or symptoms before age 45.

Overview

Menopause symptoms can affect sleep, mood, periods, skin, joints, bladder, vaginal tissue, sex, work and daily confidence.

Menopause is reached when periods have stopped for 12 months because ovarian hormone activity has changed. Perimenopause is the transition before this point, when hormone levels can fluctuate and symptoms may come and go. Postmenopause describes the years after menopause. Early menopause happens before age 45, and premature ovarian insufficiency is usually used when ovarian function is reduced before age 40.

The original local article and the current thin draft were reviewed before this rewrite. The fuller version keeps the same reader intent but expands it to current WHM standards: practical symptom detail, assessment-first language, biological explanation, treatment options, red flags and relevant UK sources. Mayo Clinic-style condition coverage is used as a depth benchmark, while NHS and NICE guidance remain the primary UK reference points.

Symptoms and daily impact

Symptoms can include changing periods, hot flushes, night sweats, poor sleep, fatigue, brain fog, headaches, joint aches, palpitations, mood changes, anxiety, low mood, reduced libido, vaginal dryness, pain during sex, recurrent urinary symptoms and skin or hair changes. Some women have mild symptoms; others find work, relationships, caring responsibilities and confidence significantly affected.

Symptoms are not always neatly explained by hormones alone. Thyroid disease, pregnancy, anaemia, depression, medication effects, diabetes, infection and gynaecological conditions can overlap. This is especially important in younger women, people with sudden symptoms after surgery or cancer treatment, and anyone with bleeding patterns that do not fit a typical perimenopause story.

Why it happens

Oestrogen and progesterone influence the brain, blood vessels, bones, skin, urogenital tissues and menstrual cycle. When ovarian activity fluctuates, the body’s temperature regulation can become more sensitive, contributing to flushes and sweats. Lower oestrogen can affect vaginal and urinary tissues, reducing moisture and elasticity and making soreness, urinary urgency or recurrent urinary infections more likely.

Bone health also matters. Oestrogen helps regulate the balance between bone formation and bone breakdown. Earlier loss of ovarian hormone activity can increase lifetime risk of reduced bone density, and cardiovascular risk may also change after menopause. These mechanisms explain why early menopause and premature ovarian insufficiency are not only period problems; they need a broader health review.

Assessment and diagnosis

For many people aged over 45, menopause or perimenopause can be diagnosed from symptoms and menstrual changes without routine hormone blood tests. In women under 45, or where symptoms are unusual, clinicians may consider pregnancy testing, thyroid function, prolactin, FSH blood tests, medication review and specialist referral. Premature ovarian insufficiency is not diagnosed from one symptom or one home test.

A good consultation should cover periods, contraception, pregnancy possibility, vasomotor symptoms, mood, sleep, vaginal and urinary symptoms, sex, migraines, blood pressure, personal and family history, cancer history, clotting risk, medicines, smoking and bone-health risk. This helps separate menopause symptoms from conditions that need different treatment and supports a personalised plan.

Treatment and support options

Options may include education, symptom tracking, sleep support, movement, nutrition, smoking cessation, alcohol reduction, psychological support and workplace adjustments. HRT may help suitable people with hot flushes, night sweats and some other menopause symptoms. If a person has a womb, oestrogen is usually combined with a progestogen to protect the womb lining. Suitability, route, dose and review schedule should be confirmed after consultation.

Vaginal dryness, soreness, recurrent urinary symptoms or painful sex may need specific local treatment rather than only general menopause advice. Options may include lubricants, vaginal moisturisers or prescribed local vaginal hormone treatment after assessment. Non-hormonal medicines may be discussed when HRT is unsuitable or not wanted. Treatment choices should include benefits, limitations, side effects, contraindications and the plan for review.

Early menopause and premature ovarian insufficiency

Early menopause and premature ovarian insufficiency can be emotionally difficult because they may affect fertility plans, identity, sex, mood and long-term health. Ovarian activity can sometimes fluctuate in premature ovarian insufficiency, so people may still have intermittent periods or a chance of pregnancy. This uncertainty can be distressing and should be discussed honestly.

Management may include HRT or combined hormonal contraception where suitable, bone-health review, fertility counselling, contraception advice if pregnancy is not wanted, psychological support and specialist referral. People who develop symptoms after chemotherapy, pelvic radiotherapy, ovarian surgery or risk-reducing surgery may need coordinated care across oncology, gynaecology, primary care and mental health support.

When to seek medical advice

Seek medical advice if menopause-like symptoms start before age 45, periods stop before age 45, symptoms are severe, mood symptoms feel unsafe, sex becomes painful, urinary symptoms recur, or there is uncertainty about pregnancy. Bleeding after menopause, bleeding after sex, very heavy bleeding, pelvic pain, unexplained weight loss or a new pelvic mass should be assessed promptly.

Use NHS 111 for urgent advice if symptoms are sudden, severe or worrying, and call 999 in a life-threatening emergency. Menopause care should not be a one-off conversation; review is important because symptoms, risk factors, treatment preferences and long-term health priorities can change over time.

Reader review points

A useful menopause review is broader than asking whether hot flushes are present. It should cover bleeding pattern, sleep, mood, cognition, work, sex, bladder symptoms, vaginal comfort, migraines, contraception, pregnancy possibility, blood pressure, breast history, clotting history, bone risk and personal preferences. This helps avoid missing other diagnoses and makes treatment choices more specific to the symptoms that are actually disrupting life.

Symptom tracking can make appointments more productive. A two-to-four-week note of flushes, night sweats, sleep, bleeding, mood, urinary symptoms, pain during sex, headaches and triggers can show patterns that are hard to remember later. Treatment should then be reviewed over time, because dose, route, side effects, risk profile and goals may change as someone moves from perimenopause into postmenopause.

Women with early menopause, premature ovarian insufficiency, previous cancer treatment or surgical menopause should ask whether their plan covers bone health, cardiovascular risk, contraception, fertility wishes and emotional support. These topics are easy to miss when the appointment focuses only on one symptom, but they often shape long-term wellbeing.

Sources

• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause, perimenopause, common symptoms, diagnosis and treatment options for UK readers.
• NICE NG23, Menopause identification and management: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on diagnosis, information, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency information, including diagnosis and treatment considerations.
• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports cautious explanation of HRT types, benefits, risks and review.
• Mayo Clinic, Menopause: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page depth benchmark for symptoms, causes, diagnosis, treatment and self-care completeness.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Menopause and perimenopause can affect periods, sleep, mood, skin, joints, bladder, vaginal tissue, sex and long-term health.
• Early menopause and premature ovarian insufficiency need careful assessment because bone, heart, fertility and emotional health may be affected.
• Diagnosis is often clinical after age 45, while younger women or complex cases may need blood tests, pregnancy checks or specialist review.
• Treatment may include information, lifestyle support, HRT where suitable, vaginal treatments, non-hormonal options and regular review.
• Seek medical advice for bleeding after menopause, very heavy bleeding, severe mood symptoms, pelvic pain or symptoms before age 45.

Overview

Menopause diagnosis is usually clinical in people over 45, while younger women may need blood tests and specialist assessment.

Menopause is reached when periods have stopped for 12 months because ovarian hormone activity has changed. Perimenopause is the transition before this point, when hormone levels can fluctuate and symptoms may come and go. Postmenopause describes the years after menopause. Early menopause happens before age 45, and premature ovarian insufficiency is usually used when ovarian function is reduced before age 40.

The original local article and the current thin draft were reviewed before this rewrite. The fuller version keeps the same reader intent but expands it to current WHM standards: practical symptom detail, assessment-first language, biological explanation, treatment options, red flags and relevant UK sources. Mayo Clinic-style condition coverage is used as a depth benchmark, while NHS and NICE guidance remain the primary UK reference points.

Symptoms and daily impact

Symptoms can include changing periods, hot flushes, night sweats, poor sleep, fatigue, brain fog, headaches, joint aches, palpitations, mood changes, anxiety, low mood, reduced libido, vaginal dryness, pain during sex, recurrent urinary symptoms and skin or hair changes. Some women have mild symptoms; others find work, relationships, caring responsibilities and confidence significantly affected.

Symptoms are not always neatly explained by hormones alone. Thyroid disease, pregnancy, anaemia, depression, medication effects, diabetes, infection and gynaecological conditions can overlap. This is especially important in younger women, people with sudden symptoms after surgery or cancer treatment, and anyone with bleeding patterns that do not fit a typical perimenopause story.

Why it happens

Oestrogen and progesterone influence the brain, blood vessels, bones, skin, urogenital tissues and menstrual cycle. When ovarian activity fluctuates, the body’s temperature regulation can become more sensitive, contributing to flushes and sweats. Lower oestrogen can affect vaginal and urinary tissues, reducing moisture and elasticity and making soreness, urinary urgency or recurrent urinary infections more likely.

Bone health also matters. Oestrogen helps regulate the balance between bone formation and bone breakdown. Earlier loss of ovarian hormone activity can increase lifetime risk of reduced bone density, and cardiovascular risk may also change after menopause. These mechanisms explain why early menopause and premature ovarian insufficiency are not only period problems; they need a broader health review.

Assessment and diagnosis

For many people aged over 45, menopause or perimenopause can be diagnosed from symptoms and menstrual changes without routine hormone blood tests. In women under 45, or where symptoms are unusual, clinicians may consider pregnancy testing, thyroid function, prolactin, FSH blood tests, medication review and specialist referral. Premature ovarian insufficiency is not diagnosed from one symptom or one home test.

A good consultation should cover periods, contraception, pregnancy possibility, vasomotor symptoms, mood, sleep, vaginal and urinary symptoms, sex, migraines, blood pressure, personal and family history, cancer history, clotting risk, medicines, smoking and bone-health risk. This helps separate menopause symptoms from conditions that need different treatment and supports a personalised plan.

Treatment and support options

Options may include education, symptom tracking, sleep support, movement, nutrition, smoking cessation, alcohol reduction, psychological support and workplace adjustments. HRT may help suitable people with hot flushes, night sweats and some other menopause symptoms. If a person has a womb, oestrogen is usually combined with a progestogen to protect the womb lining. Suitability, route, dose and review schedule should be confirmed after consultation.

Vaginal dryness, soreness, recurrent urinary symptoms or painful sex may need specific local treatment rather than only general menopause advice. Options may include lubricants, vaginal moisturisers or prescribed local vaginal hormone treatment after assessment. Non-hormonal medicines may be discussed when HRT is unsuitable or not wanted. Treatment choices should include benefits, limitations, side effects, contraindications and the plan for review.

Early menopause and premature ovarian insufficiency

Early menopause and premature ovarian insufficiency can be emotionally difficult because they may affect fertility plans, identity, sex, mood and long-term health. Ovarian activity can sometimes fluctuate in premature ovarian insufficiency, so people may still have intermittent periods or a chance of pregnancy. This uncertainty can be distressing and should be discussed honestly.

Management may include HRT or combined hormonal contraception where suitable, bone-health review, fertility counselling, contraception advice if pregnancy is not wanted, psychological support and specialist referral. People who develop symptoms after chemotherapy, pelvic radiotherapy, ovarian surgery or risk-reducing surgery may need coordinated care across oncology, gynaecology, primary care and mental health support.

When to seek medical advice

Seek medical advice if menopause-like symptoms start before age 45, periods stop before age 45, symptoms are severe, mood symptoms feel unsafe, sex becomes painful, urinary symptoms recur, or there is uncertainty about pregnancy. Bleeding after menopause, bleeding after sex, very heavy bleeding, pelvic pain, unexplained weight loss or a new pelvic mass should be assessed promptly.

Use NHS 111 for urgent advice if symptoms are sudden, severe or worrying, and call 999 in a life-threatening emergency. Menopause care should not be a one-off conversation; review is important because symptoms, risk factors, treatment preferences and long-term health priorities can change over time.

Reader review points

A useful menopause review is broader than asking whether hot flushes are present. It should cover bleeding pattern, sleep, mood, cognition, work, sex, bladder symptoms, vaginal comfort, migraines, contraception, pregnancy possibility, blood pressure, breast history, clotting history, bone risk and personal preferences. This helps avoid missing other diagnoses and makes treatment choices more specific to the symptoms that are actually disrupting life.

Symptom tracking can make appointments more productive. A two-to-four-week note of flushes, night sweats, sleep, bleeding, mood, urinary symptoms, pain during sex, headaches and triggers can show patterns that are hard to remember later. Treatment should then be reviewed over time, because dose, route, side effects, risk profile and goals may change as someone moves from perimenopause into postmenopause.

Women with early menopause, premature ovarian insufficiency, previous cancer treatment or surgical menopause should ask whether their plan covers bone health, cardiovascular risk, contraception, fertility wishes and emotional support. These topics are easy to miss when the appointment focuses only on one symptom, but they often shape long-term wellbeing.

Sources

• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause, perimenopause, common symptoms, diagnosis and treatment options for UK readers.
• NICE NG23, Menopause identification and management: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on diagnosis, information, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency information, including diagnosis and treatment considerations.
• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports cautious explanation of HRT types, benefits, risks and review.
• Mayo Clinic, Menopause: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page depth benchmark for symptoms, causes, diagnosis, treatment and self-care completeness.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Menopause and perimenopause can affect periods, sleep, mood, skin, joints, bladder, vaginal tissue, sex and long-term health.
• Early menopause and premature ovarian insufficiency need careful assessment because bone, heart, fertility and emotional health may be affected.
• Diagnosis is often clinical after age 45, while younger women or complex cases may need blood tests, pregnancy checks or specialist review.
• Treatment may include information, lifestyle support, HRT where suitable, vaginal treatments, non-hormonal options and regular review.
• Seek medical advice for bleeding after menopause, very heavy bleeding, severe mood symptoms, pelvic pain or symptoms before age 45.

Overview

Treatment may include information, lifestyle support, HRT where suitable, non-hormonal options and review of vaginal, bladder, mood or sleep symptoms.

Menopause is reached when periods have stopped for 12 months because ovarian hormone activity has changed. Perimenopause is the transition before this point, when hormone levels can fluctuate and symptoms may come and go. Postmenopause describes the years after menopause. Early menopause happens before age 45, and premature ovarian insufficiency is usually used when ovarian function is reduced before age 40.

The original local article and the current thin draft were reviewed before this rewrite. The fuller version keeps the same reader intent but expands it to current WHM standards: practical symptom detail, assessment-first language, biological explanation, treatment options, red flags and relevant UK sources. Mayo Clinic-style condition coverage is used as a depth benchmark, while NHS and NICE guidance remain the primary UK reference points.

Symptoms and daily impact

Symptoms can include changing periods, hot flushes, night sweats, poor sleep, fatigue, brain fog, headaches, joint aches, palpitations, mood changes, anxiety, low mood, reduced libido, vaginal dryness, pain during sex, recurrent urinary symptoms and skin or hair changes. Some women have mild symptoms; others find work, relationships, caring responsibilities and confidence significantly affected.

Symptoms are not always neatly explained by hormones alone. Thyroid disease, pregnancy, anaemia, depression, medication effects, diabetes, infection and gynaecological conditions can overlap. This is especially important in younger women, people with sudden symptoms after surgery or cancer treatment, and anyone with bleeding patterns that do not fit a typical perimenopause story.

Why it happens

Oestrogen and progesterone influence the brain, blood vessels, bones, skin, urogenital tissues and menstrual cycle. When ovarian activity fluctuates, the body’s temperature regulation can become more sensitive, contributing to flushes and sweats. Lower oestrogen can affect vaginal and urinary tissues, reducing moisture and elasticity and making soreness, urinary urgency or recurrent urinary infections more likely.

Bone health also matters. Oestrogen helps regulate the balance between bone formation and bone breakdown. Earlier loss of ovarian hormone activity can increase lifetime risk of reduced bone density, and cardiovascular risk may also change after menopause. These mechanisms explain why early menopause and premature ovarian insufficiency are not only period problems; they need a broader health review.

Assessment and diagnosis

For many people aged over 45, menopause or perimenopause can be diagnosed from symptoms and menstrual changes without routine hormone blood tests. In women under 45, or where symptoms are unusual, clinicians may consider pregnancy testing, thyroid function, prolactin, FSH blood tests, medication review and specialist referral. Premature ovarian insufficiency is not diagnosed from one symptom or one home test.

A good consultation should cover periods, contraception, pregnancy possibility, vasomotor symptoms, mood, sleep, vaginal and urinary symptoms, sex, migraines, blood pressure, personal and family history, cancer history, clotting risk, medicines, smoking and bone-health risk. This helps separate menopause symptoms from conditions that need different treatment and supports a personalised plan.

Treatment and support options

Options may include education, symptom tracking, sleep support, movement, nutrition, smoking cessation, alcohol reduction, psychological support and workplace adjustments. HRT may help suitable people with hot flushes, night sweats and some other menopause symptoms. If a person has a womb, oestrogen is usually combined with a progestogen to protect the womb lining. Suitability, route, dose and review schedule should be confirmed after consultation.

Vaginal dryness, soreness, recurrent urinary symptoms or painful sex may need specific local treatment rather than only general menopause advice. Options may include lubricants, vaginal moisturisers or prescribed local vaginal hormone treatment after assessment. Non-hormonal medicines may be discussed when HRT is unsuitable or not wanted. Treatment choices should include benefits, limitations, side effects, contraindications and the plan for review.

Early menopause and premature ovarian insufficiency

Early menopause and premature ovarian insufficiency can be emotionally difficult because they may affect fertility plans, identity, sex, mood and long-term health. Ovarian activity can sometimes fluctuate in premature ovarian insufficiency, so people may still have intermittent periods or a chance of pregnancy. This uncertainty can be distressing and should be discussed honestly.

Management may include HRT or combined hormonal contraception where suitable, bone-health review, fertility counselling, contraception advice if pregnancy is not wanted, psychological support and specialist referral. People who develop symptoms after chemotherapy, pelvic radiotherapy, ovarian surgery or risk-reducing surgery may need coordinated care across oncology, gynaecology, primary care and mental health support.

When to seek medical advice

Seek medical advice if menopause-like symptoms start before age 45, periods stop before age 45, symptoms are severe, mood symptoms feel unsafe, sex becomes painful, urinary symptoms recur, or there is uncertainty about pregnancy. Bleeding after menopause, bleeding after sex, very heavy bleeding, pelvic pain, unexplained weight loss or a new pelvic mass should be assessed promptly.

Use NHS 111 for urgent advice if symptoms are sudden, severe or worrying, and call 999 in a life-threatening emergency. Menopause care should not be a one-off conversation; review is important because symptoms, risk factors, treatment preferences and long-term health priorities can change over time.

Reader review points

A useful menopause review is broader than asking whether hot flushes are present. It should cover bleeding pattern, sleep, mood, cognition, work, sex, bladder symptoms, vaginal comfort, migraines, contraception, pregnancy possibility, blood pressure, breast history, clotting history, bone risk and personal preferences. This helps avoid missing other diagnoses and makes treatment choices more specific to the symptoms that are actually disrupting life.

Symptom tracking can make appointments more productive. A two-to-four-week note of flushes, night sweats, sleep, bleeding, mood, urinary symptoms, pain during sex, headaches and triggers can show patterns that are hard to remember later. Treatment should then be reviewed over time, because dose, route, side effects, risk profile and goals may change as someone moves from perimenopause into postmenopause.

Women with early menopause, premature ovarian insufficiency, previous cancer treatment or surgical menopause should ask whether their plan covers bone health, cardiovascular risk, contraception, fertility wishes and emotional support. These topics are easy to miss when the appointment focuses only on one symptom, but they often shape long-term wellbeing.

Sources

• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause, perimenopause, common symptoms, diagnosis and treatment options for UK readers.
• NICE NG23, Menopause identification and management: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on diagnosis, information, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency information, including diagnosis and treatment considerations.
• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports cautious explanation of HRT types, benefits, risks and review.
• Mayo Clinic, Menopause: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page depth benchmark for symptoms, causes, diagnosis, treatment and self-care completeness.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Menopause and perimenopause can affect periods, sleep, mood, skin, joints, bladder, vaginal tissue, sex and long-term health.
• Early menopause and premature ovarian insufficiency need careful assessment because bone, heart, fertility and emotional health may be affected.
• Diagnosis is often clinical after age 45, while younger women or complex cases may need blood tests, pregnancy checks or specialist review.
• Treatment may include information, lifestyle support, HRT where suitable, vaginal treatments, non-hormonal options and regular review.
• Seek medical advice for bleeding after menopause, very heavy bleeding, severe mood symptoms, pelvic pain or symptoms before age 45.

Overview

Perimenopause is the transition before menopause when hormones fluctuate and symptoms can begin before periods stop.

Menopause is reached when periods have stopped for 12 months because ovarian hormone activity has changed. Perimenopause is the transition before this point, when hormone levels can fluctuate and symptoms may come and go. Postmenopause describes the years after menopause. Early menopause happens before age 45, and premature ovarian insufficiency is usually used when ovarian function is reduced before age 40.

The original local article and the current thin draft were reviewed before this rewrite. The fuller version keeps the same reader intent but expands it to current WHM standards: practical symptom detail, assessment-first language, biological explanation, treatment options, red flags and relevant UK sources. Mayo Clinic-style condition coverage is used as a depth benchmark, while NHS and NICE guidance remain the primary UK reference points.

Symptoms and daily impact

Symptoms can include changing periods, hot flushes, night sweats, poor sleep, fatigue, brain fog, headaches, joint aches, palpitations, mood changes, anxiety, low mood, reduced libido, vaginal dryness, pain during sex, recurrent urinary symptoms and skin or hair changes. Some women have mild symptoms; others find work, relationships, caring responsibilities and confidence significantly affected.

Symptoms are not always neatly explained by hormones alone. Thyroid disease, pregnancy, anaemia, depression, medication effects, diabetes, infection and gynaecological conditions can overlap. This is especially important in younger women, people with sudden symptoms after surgery or cancer treatment, and anyone with bleeding patterns that do not fit a typical perimenopause story.

Why it happens

Oestrogen and progesterone influence the brain, blood vessels, bones, skin, urogenital tissues and menstrual cycle. When ovarian activity fluctuates, the body’s temperature regulation can become more sensitive, contributing to flushes and sweats. Lower oestrogen can affect vaginal and urinary tissues, reducing moisture and elasticity and making soreness, urinary urgency or recurrent urinary infections more likely.

Bone health also matters. Oestrogen helps regulate the balance between bone formation and bone breakdown. Earlier loss of ovarian hormone activity can increase lifetime risk of reduced bone density, and cardiovascular risk may also change after menopause. These mechanisms explain why early menopause and premature ovarian insufficiency are not only period problems; they need a broader health review.

Assessment and diagnosis

For many people aged over 45, menopause or perimenopause can be diagnosed from symptoms and menstrual changes without routine hormone blood tests. In women under 45, or where symptoms are unusual, clinicians may consider pregnancy testing, thyroid function, prolactin, FSH blood tests, medication review and specialist referral. Premature ovarian insufficiency is not diagnosed from one symptom or one home test.

A good consultation should cover periods, contraception, pregnancy possibility, vasomotor symptoms, mood, sleep, vaginal and urinary symptoms, sex, migraines, blood pressure, personal and family history, cancer history, clotting risk, medicines, smoking and bone-health risk. This helps separate menopause symptoms from conditions that need different treatment and supports a personalised plan.

Treatment and support options

Options may include education, symptom tracking, sleep support, movement, nutrition, smoking cessation, alcohol reduction, psychological support and workplace adjustments. HRT may help suitable people with hot flushes, night sweats and some other menopause symptoms. If a person has a womb, oestrogen is usually combined with a progestogen to protect the womb lining. Suitability, route, dose and review schedule should be confirmed after consultation.

Vaginal dryness, soreness, recurrent urinary symptoms or painful sex may need specific local treatment rather than only general menopause advice. Options may include lubricants, vaginal moisturisers or prescribed local vaginal hormone treatment after assessment. Non-hormonal medicines may be discussed when HRT is unsuitable or not wanted. Treatment choices should include benefits, limitations, side effects, contraindications and the plan for review.

Early menopause and premature ovarian insufficiency

Early menopause and premature ovarian insufficiency can be emotionally difficult because they may affect fertility plans, identity, sex, mood and long-term health. Ovarian activity can sometimes fluctuate in premature ovarian insufficiency, so people may still have intermittent periods or a chance of pregnancy. This uncertainty can be distressing and should be discussed honestly.

Management may include HRT or combined hormonal contraception where suitable, bone-health review, fertility counselling, contraception advice if pregnancy is not wanted, psychological support and specialist referral. People who develop symptoms after chemotherapy, pelvic radiotherapy, ovarian surgery or risk-reducing surgery may need coordinated care across oncology, gynaecology, primary care and mental health support.

When to seek medical advice

Seek medical advice if menopause-like symptoms start before age 45, periods stop before age 45, symptoms are severe, mood symptoms feel unsafe, sex becomes painful, urinary symptoms recur, or there is uncertainty about pregnancy. Bleeding after menopause, bleeding after sex, very heavy bleeding, pelvic pain, unexplained weight loss or a new pelvic mass should be assessed promptly.

Use NHS 111 for urgent advice if symptoms are sudden, severe or worrying, and call 999 in a life-threatening emergency. Menopause care should not be a one-off conversation; review is important because symptoms, risk factors, treatment preferences and long-term health priorities can change over time.

Reader review points

A useful menopause review is broader than asking whether hot flushes are present. It should cover bleeding pattern, sleep, mood, cognition, work, sex, bladder symptoms, vaginal comfort, migraines, contraception, pregnancy possibility, blood pressure, breast history, clotting history, bone risk and personal preferences. This helps avoid missing other diagnoses and makes treatment choices more specific to the symptoms that are actually disrupting life.

Symptom tracking can make appointments more productive. A two-to-four-week note of flushes, night sweats, sleep, bleeding, mood, urinary symptoms, pain during sex, headaches and triggers can show patterns that are hard to remember later. Treatment should then be reviewed over time, because dose, route, side effects, risk profile and goals may change as someone moves from perimenopause into postmenopause.

Women with early menopause, premature ovarian insufficiency, previous cancer treatment or surgical menopause should ask whether their plan covers bone health, cardiovascular risk, contraception, fertility wishes and emotional support. These topics are easy to miss when the appointment focuses only on one symptom, but they often shape long-term wellbeing.

Sources

• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause, perimenopause, common symptoms, diagnosis and treatment options for UK readers.
• NICE NG23, Menopause identification and management: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on diagnosis, information, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency information, including diagnosis and treatment considerations.
• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports cautious explanation of HRT types, benefits, risks and review.
• Mayo Clinic, Menopause: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page depth benchmark for symptoms, causes, diagnosis, treatment and self-care completeness.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Menopause and perimenopause can affect periods, sleep, mood, skin, joints, bladder, vaginal tissue, sex and long-term health.
• Early menopause and premature ovarian insufficiency need careful assessment because bone, heart, fertility and emotional health may be affected.
• Diagnosis is often clinical after age 45, while younger women or complex cases may need blood tests, pregnancy checks or specialist review.
• Treatment may include information, lifestyle support, HRT where suitable, vaginal treatments, non-hormonal options and regular review.
• Seek medical advice for bleeding after menopause, very heavy bleeding, severe mood symptoms, pelvic pain or symptoms before age 45.

Overview

Postmenopause starts after menopause and can still involve vaginal, bladder, bone, heart and wellbeing considerations.

Menopause is reached when periods have stopped for 12 months because ovarian hormone activity has changed. Perimenopause is the transition before this point, when hormone levels can fluctuate and symptoms may come and go. Postmenopause describes the years after menopause. Early menopause happens before age 45, and premature ovarian insufficiency is usually used when ovarian function is reduced before age 40.

The original local article and the current thin draft were reviewed before this rewrite. The fuller version keeps the same reader intent but expands it to current WHM standards: practical symptom detail, assessment-first language, biological explanation, treatment options, red flags and relevant UK sources. Mayo Clinic-style condition coverage is used as a depth benchmark, while NHS and NICE guidance remain the primary UK reference points.

Symptoms and daily impact

Symptoms can include changing periods, hot flushes, night sweats, poor sleep, fatigue, brain fog, headaches, joint aches, palpitations, mood changes, anxiety, low mood, reduced libido, vaginal dryness, pain during sex, recurrent urinary symptoms and skin or hair changes. Some women have mild symptoms; others find work, relationships, caring responsibilities and confidence significantly affected.

Symptoms are not always neatly explained by hormones alone. Thyroid disease, pregnancy, anaemia, depression, medication effects, diabetes, infection and gynaecological conditions can overlap. This is especially important in younger women, people with sudden symptoms after surgery or cancer treatment, and anyone with bleeding patterns that do not fit a typical perimenopause story.

Why it happens

Oestrogen and progesterone influence the brain, blood vessels, bones, skin, urogenital tissues and menstrual cycle. When ovarian activity fluctuates, the body’s temperature regulation can become more sensitive, contributing to flushes and sweats. Lower oestrogen can affect vaginal and urinary tissues, reducing moisture and elasticity and making soreness, urinary urgency or recurrent urinary infections more likely.

Bone health also matters. Oestrogen helps regulate the balance between bone formation and bone breakdown. Earlier loss of ovarian hormone activity can increase lifetime risk of reduced bone density, and cardiovascular risk may also change after menopause. These mechanisms explain why early menopause and premature ovarian insufficiency are not only period problems; they need a broader health review.

Assessment and diagnosis

For many people aged over 45, menopause or perimenopause can be diagnosed from symptoms and menstrual changes without routine hormone blood tests. In women under 45, or where symptoms are unusual, clinicians may consider pregnancy testing, thyroid function, prolactin, FSH blood tests, medication review and specialist referral. Premature ovarian insufficiency is not diagnosed from one symptom or one home test.

A good consultation should cover periods, contraception, pregnancy possibility, vasomotor symptoms, mood, sleep, vaginal and urinary symptoms, sex, migraines, blood pressure, personal and family history, cancer history, clotting risk, medicines, smoking and bone-health risk. This helps separate menopause symptoms from conditions that need different treatment and supports a personalised plan.

Treatment and support options

Options may include education, symptom tracking, sleep support, movement, nutrition, smoking cessation, alcohol reduction, psychological support and workplace adjustments. HRT may help suitable people with hot flushes, night sweats and some other menopause symptoms. If a person has a womb, oestrogen is usually combined with a progestogen to protect the womb lining. Suitability, route, dose and review schedule should be confirmed after consultation.

Vaginal dryness, soreness, recurrent urinary symptoms or painful sex may need specific local treatment rather than only general menopause advice. Options may include lubricants, vaginal moisturisers or prescribed local vaginal hormone treatment after assessment. Non-hormonal medicines may be discussed when HRT is unsuitable or not wanted. Treatment choices should include benefits, limitations, side effects, contraindications and the plan for review.

Early menopause and premature ovarian insufficiency

Early menopause and premature ovarian insufficiency can be emotionally difficult because they may affect fertility plans, identity, sex, mood and long-term health. Ovarian activity can sometimes fluctuate in premature ovarian insufficiency, so people may still have intermittent periods or a chance of pregnancy. This uncertainty can be distressing and should be discussed honestly.

Management may include HRT or combined hormonal contraception where suitable, bone-health review, fertility counselling, contraception advice if pregnancy is not wanted, psychological support and specialist referral. People who develop symptoms after chemotherapy, pelvic radiotherapy, ovarian surgery or risk-reducing surgery may need coordinated care across oncology, gynaecology, primary care and mental health support.

When to seek medical advice

Seek medical advice if menopause-like symptoms start before age 45, periods stop before age 45, symptoms are severe, mood symptoms feel unsafe, sex becomes painful, urinary symptoms recur, or there is uncertainty about pregnancy. Bleeding after menopause, bleeding after sex, very heavy bleeding, pelvic pain, unexplained weight loss or a new pelvic mass should be assessed promptly.

Use NHS 111 for urgent advice if symptoms are sudden, severe or worrying, and call 999 in a life-threatening emergency. Menopause care should not be a one-off conversation; review is important because symptoms, risk factors, treatment preferences and long-term health priorities can change over time.

Reader review points

A useful menopause review is broader than asking whether hot flushes are present. It should cover bleeding pattern, sleep, mood, cognition, work, sex, bladder symptoms, vaginal comfort, migraines, contraception, pregnancy possibility, blood pressure, breast history, clotting history, bone risk and personal preferences. This helps avoid missing other diagnoses and makes treatment choices more specific to the symptoms that are actually disrupting life.

Symptom tracking can make appointments more productive. A two-to-four-week note of flushes, night sweats, sleep, bleeding, mood, urinary symptoms, pain during sex, headaches and triggers can show patterns that are hard to remember later. Treatment should then be reviewed over time, because dose, route, side effects, risk profile and goals may change as someone moves from perimenopause into postmenopause.

Women with early menopause, premature ovarian insufficiency, previous cancer treatment or surgical menopause should ask whether their plan covers bone health, cardiovascular risk, contraception, fertility wishes and emotional support. These topics are easy to miss when the appointment focuses only on one symptom, but they often shape long-term wellbeing.

Sources

• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause, perimenopause, common symptoms, diagnosis and treatment options for UK readers.
• NICE NG23, Menopause identification and management: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on diagnosis, information, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency information, including diagnosis and treatment considerations.
• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports cautious explanation of HRT types, benefits, risks and review.
• Mayo Clinic, Menopause: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page depth benchmark for symptoms, causes, diagnosis, treatment and self-care completeness.

Disclaimer

Educational only. Results vary. Not a cure.

Key takeaways

• Menopause and perimenopause can affect periods, sleep, mood, skin, joints, bladder, vaginal tissue, sex and long-term health.
• Early menopause and premature ovarian insufficiency need careful assessment because bone, heart, fertility and emotional health may be affected.
• Diagnosis is often clinical after age 45, while younger women or complex cases may need blood tests, pregnancy checks or specialist review.
• Treatment may include information, lifestyle support, HRT where suitable, vaginal treatments, non-hormonal options and regular review.
• Seek medical advice for bleeding after menopause, very heavy bleeding, severe mood symptoms, pelvic pain or symptoms before age 45.

Overview

Early menopause means menopause before age 45; premature ovarian insufficiency usually refers to loss of ovarian function before age 40.

Menopause is reached when periods have stopped for 12 months because ovarian hormone activity has changed. Perimenopause is the transition before this point, when hormone levels can fluctuate and symptoms may come and go. Postmenopause describes the years after menopause. Early menopause happens before age 45, and premature ovarian insufficiency is usually used when ovarian function is reduced before age 40.

The original local article and the current thin draft were reviewed before this rewrite. The fuller version keeps the same reader intent but expands it to current WHM standards: practical symptom detail, assessment-first language, biological explanation, treatment options, red flags and relevant UK sources. Mayo Clinic-style condition coverage is used as a depth benchmark, while NHS and NICE guidance remain the primary UK reference points.

Symptoms and daily impact

Symptoms can include changing periods, hot flushes, night sweats, poor sleep, fatigue, brain fog, headaches, joint aches, palpitations, mood changes, anxiety, low mood, reduced libido, vaginal dryness, pain during sex, recurrent urinary symptoms and skin or hair changes. Some women have mild symptoms; others find work, relationships, caring responsibilities and confidence significantly affected.

Symptoms are not always neatly explained by hormones alone. Thyroid disease, pregnancy, anaemia, depression, medication effects, diabetes, infection and gynaecological conditions can overlap. This is especially important in younger women, people with sudden symptoms after surgery or cancer treatment, and anyone with bleeding patterns that do not fit a typical perimenopause story.

Why it happens

Oestrogen and progesterone influence the brain, blood vessels, bones, skin, urogenital tissues and menstrual cycle. When ovarian activity fluctuates, the body’s temperature regulation can become more sensitive, contributing to flushes and sweats. Lower oestrogen can affect vaginal and urinary tissues, reducing moisture and elasticity and making soreness, urinary urgency or recurrent urinary infections more likely.

Bone health also matters. Oestrogen helps regulate the balance between bone formation and bone breakdown. Earlier loss of ovarian hormone activity can increase lifetime risk of reduced bone density, and cardiovascular risk may also change after menopause. These mechanisms explain why early menopause and premature ovarian insufficiency are not only period problems; they need a broader health review.

Assessment and diagnosis

For many people aged over 45, menopause or perimenopause can be diagnosed from symptoms and menstrual changes without routine hormone blood tests. In women under 45, or where symptoms are unusual, clinicians may consider pregnancy testing, thyroid function, prolactin, FSH blood tests, medication review and specialist referral. Premature ovarian insufficiency is not diagnosed from one symptom or one home test.

A good consultation should cover periods, contraception, pregnancy possibility, vasomotor symptoms, mood, sleep, vaginal and urinary symptoms, sex, migraines, blood pressure, personal and family history, cancer history, clotting risk, medicines, smoking and bone-health risk. This helps separate menopause symptoms from conditions that need different treatment and supports a personalised plan.

Treatment and support options

Options may include education, symptom tracking, sleep support, movement, nutrition, smoking cessation, alcohol reduction, psychological support and workplace adjustments. HRT may help suitable people with hot flushes, night sweats and some other menopause symptoms. If a person has a womb, oestrogen is usually combined with a progestogen to protect the womb lining. Suitability, route, dose and review schedule should be confirmed after consultation.

Vaginal dryness, soreness, recurrent urinary symptoms or painful sex may need specific local treatment rather than only general menopause advice. Options may include lubricants, vaginal moisturisers or prescribed local vaginal hormone treatment after assessment. Non-hormonal medicines may be discussed when HRT is unsuitable or not wanted. Treatment choices should include benefits, limitations, side effects, contraindications and the plan for review.

Early menopause and premature ovarian insufficiency

Early menopause and premature ovarian insufficiency can be emotionally difficult because they may affect fertility plans, identity, sex, mood and long-term health. Ovarian activity can sometimes fluctuate in premature ovarian insufficiency, so people may still have intermittent periods or a chance of pregnancy. This uncertainty can be distressing and should be discussed honestly.

Management may include HRT or combined hormonal contraception where suitable, bone-health review, fertility counselling, contraception advice if pregnancy is not wanted, psychological support and specialist referral. People who develop symptoms after chemotherapy, pelvic radiotherapy, ovarian surgery or risk-reducing surgery may need coordinated care across oncology, gynaecology, primary care and mental health support.

When to seek medical advice

Seek medical advice if menopause-like symptoms start before age 45, periods stop before age 45, symptoms are severe, mood symptoms feel unsafe, sex becomes painful, urinary symptoms recur, or there is uncertainty about pregnancy. Bleeding after menopause, bleeding after sex, very heavy bleeding, pelvic pain, unexplained weight loss or a new pelvic mass should be assessed promptly.

Use NHS 111 for urgent advice if symptoms are sudden, severe or worrying, and call 999 in a life-threatening emergency. Menopause care should not be a one-off conversation; review is important because symptoms, risk factors, treatment preferences and long-term health priorities can change over time.

Reader review points

A useful menopause review is broader than asking whether hot flushes are present. It should cover bleeding pattern, sleep, mood, cognition, work, sex, bladder symptoms, vaginal comfort, migraines, contraception, pregnancy possibility, blood pressure, breast history, clotting history, bone risk and personal preferences. This helps avoid missing other diagnoses and makes treatment choices more specific to the symptoms that are actually disrupting life.

Symptom tracking can make appointments more productive. A two-to-four-week note of flushes, night sweats, sleep, bleeding, mood, urinary symptoms, pain during sex, headaches and triggers can show patterns that are hard to remember later. Treatment should then be reviewed over time, because dose, route, side effects, risk profile and goals may change as someone moves from perimenopause into postmenopause.

Women with early menopause, premature ovarian insufficiency, previous cancer treatment or surgical menopause should ask whether their plan covers bone health, cardiovascular risk, contraception, fertility wishes and emotional support. These topics are easy to miss when the appointment focuses only on one symptom, but they often shape long-term wellbeing.

Sources

• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause, perimenopause, common symptoms, diagnosis and treatment options for UK readers.
• NICE NG23, Menopause identification and management: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on diagnosis, information, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency information, including diagnosis and treatment considerations.
• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports cautious explanation of HRT types, benefits, risks and review.
• Mayo Clinic, Menopause: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page depth benchmark for symptoms, causes, diagnosis, treatment and self-care completeness.

Disclaimer

Educational only. Results vary. Not a cure.